CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Ensysce Biosciences

For profitWebsite ↗

Also known as: Chief Medical Officer, Ensysce Biosciences | Ensysce Biosciences

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 31, 2025

Timeline

2000s

Jun 1, 2008
Ensysce Biosciences— Founded

2010s

Jan 19, 2016
Signature Therapeutics, Inc.— Acquired

Drugs by trial phase (4 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Signature Therapeutics, Inc.

Recent trials (13)

NCT06602271Lead sponsorPhase 3Mar 31, 2025
NCT06500793Lead sponsorPhase 1Nov 30, 2024
NCT06629402Lead sponsorPhase 2Oct 5, 2023
NCT05571345Study chairPhase 1Oct 5, 2022
NCT05571345Lead sponsorPhase 1Oct 5, 2022
NCT05567354Lead sponsorPhase 1Jun 10, 2022
NCT05090280Lead sponsorPhase 1Nov 30, 2021
NCT05043766Study directorPhase 1Sep 8, 2021
NCT05043766Lead sponsorPhase 1Sep 8, 2021
NCT04406415Study directorPhase 1Jun 30, 2020
NCT04406415Lead sponsorPhase 1Jun 30, 2020
NCT02454712Study directorPhase 1Nov 1, 2016
NCT02454712Lead sponsorPhase 1Nov 1, 2016

Details

Founded: San Diego, CA, US Jun 1, 2008
Last known activity: Mar 31, 2025